Activity of rifampicin in experimental tuberculosis of the guinea pig.
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006168:Guinea Pigs; D007538:Isoniazid / Q000494:pharmacology; D008171:Lung Diseases / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009929:Organ Size; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use*; D012883:Skin Ulcer / Q000188:drug therapy* / Q000473:pathology; D013154:Spleen; D013158:Splenic Diseases / Q000473:pathology; D014374:Tuberculin Test; D014376:Tuberculosis / Q000473:pathology
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin